Chiesi Ventures — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
GlycomineOct 2016
Developing therapies for congenital disorders of glycosylation combining replacement therapies with intracellular delivery vehicles.
San Francisco, US
Board seatGiacomo Chiesi· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.